Berman Capital Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$40K Buy
149
+145
+3,625% +$38.9K 0.01% 765
2021
Q2
$0 Buy
+4
New ﹤0.01% 1990
2020
Q1
Sell
-8
Closed -$2K 1604
2019
Q4
$2K Buy
+8
New +$2K ﹤0.01% 1222
2019
Q3
Sell
-7
Closed -$3K 1537
2019
Q2
$3K Buy
+7
New +$3K ﹤0.01% 1109
2019
Q1
Sell
-6
Closed -$2K 1435
2018
Q4
$2K Buy
+6
New +$2K ﹤0.01% 884